Financial giants have made a conspicuous bullish move on Hims & Hers Health. Our analysis of options history for Hims & Hers Health HIMS revealed 9 unusual trades. Delving into the details ...

We've identified the following companies as similar to Hims & Hers Health, Inc. because they operate in a related industry or sector. We also considered size, growth, and various financial metrics to ...

NEW YORK (Reuters) - U.S. telehealth company Hims & Hers Health on Wednesday said it will sell compounded versions of Novo Nordisk's popular weight-loss drug Wegovy to patients in certain ...

NEW YORK, Sept 18 (Reuters) - U.S. telehealth company Hims & Hers Health (HIMS.N), opens new tab on Wednesday said it will sell compounded versions of Novo Nordisk's (NOVOb.CO), opens new tab ...

Hims & Hers' stock decline after GLP-1 concerns is an overreaction, presenting a strong investment opportunity. Management's consistent outperformance and strategic leadership, including key hires ...

The biggest news was Hims & Hers issuing 976,341 shares of common stock to acquire Nivagen Pharmaceuticals, which does ...

In the preceding three months, 8 analysts have released ratings for Hims & Hers Health (NYSE:HIMS), presenting a wide array of perspectives from bullish to bearish. The table below provides a ...